Evaluation of Inflammatory Cytokines During COVID-19

• Conditions: Covid19

• Registration Number: NCT04824495
• Lead Sponsor: University of Vienna

Brief Summary

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Detailed Description

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

Study Timeline

• Study Start: 2021-01-07
• Study First Submitted: 2021-03-29
• Study First Submitted QC: 2021-03-29
• Status Verified: 2021-04
• Study First Posted: 2021-04-01
• Last Update Submitted: 2021-04-04
• Last Update Posted: 2021-04-06
• Primary Completion: 2021-08-31
• Study Completion: 2021-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Age > 18 years
• Confirmation of acute SARS-CoV2 infection
• Ability to provide informed consent

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cytokine level in context with clinical parameters	2 weeks

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria